|
|
|
| |
|
|
| |
The latest bowel cancer news from News Medical |
|
|
|
 | | |  Allergies show a small but significant link to later cancer risk A systematic review and meta-analysis of 28 cohort-based studies found a weak but statistically significant association between allergic diseases and later cancer incidence. The signal was strongest in the Western Pacific region and among people with asthma, but high heterogeneity and limited subgroup evidence mean the findings require caution. | | | | |  Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption was associated with about 50% lower odds of self-reported colorectal cancer. Because the study was cross-sectional, it cannot prove causation but supports further research into microbiota-targeted dietary strategies. | |
|
|
| | | | |  As human cases of flea-borne murine typhus continue to occur in South Texas, researchers are working to better understand the role cats and their fleas may play in the disease's transmission cycle. | | | | |  Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional methods that often require surgical interventions or tissue biopsies. | | | | |  Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies. | | | | |  New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender identity (SOGI) populations. | | | | |  The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later. | | | | |  A research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem. | | | | |  Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation to offer a new drug, Daraxonrasib, that based on early data nearly doubles the average survival time of patients with pancreatic cancer. | | | | |  A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need for equitable healthcare access. | |
|
|
|
|
|
|
|
